# Verification Report: peristalsis
*Generated: 2026-07-23*

## Summary
- **Critical issues:** 0
- **Warnings:** 3
- **Info:** 4

Scope: universal checks + startup-design cross-phase checks against the 5 Phase-3 deliverables (`market-analysis.md`, `competitor-landscape.md`, `target-audience.md`, `industry-trends.md`, `confidence-dashboard.md`). Cross-phase checks that require Phases 4–8 are deferred (those phases don't exist yet) and re-run at final verification.

## Critical Issues
None. No internal numeric contradictions, no unlabeled major quantitative claims, no High-confidence claim resting on a single Tier-3 source.

## Warnings

### 1. Market-size labeling leans on one shared weak basis reused across files
- **File(s):** `market-analysis.md`, `confidence-dashboard.md`, `industry-trends.md`
- **Problem:** TAM/SAM figures ($300–400M / $30M) trace to the same Tier-3 report-seller triangulation + founder-derived estimates. They are correctly labeled [Estimate]/Low confidence, but the *same weak basis* is cited in multiple places, which can read as corroboration.
- **Suggested fix:** Already flagged as a data gap and Low confidence everywhere; acceptable as-is provided Phase 7 never presents these as [Data]. No change required, monitor in financials.

### 2. Feb-2026 pain recency skew
- **File(s):** `target-audience.md`, `industry-trends.md`
- **Problem:** Some pain intensity (the "Most relevant" hijack) rides a specific Feb 2026 rollout that YouTube could partially revert; risks overstating durable demand.
- **Suggested fix:** Both files already separate durable pain (missing videos, #1) from transient (layout-of-the-month) and flag it. Adequate; carry the distinction into Phase 8 experiment design.

### 3. Invidious precedent is 2023 `[STALE]`
- **File(s):** `market-analysis.md`, `industry-trends.md`, raw/regulatory.md
- **Problem:** The strongest ToS-risk precedent is 3 years old with no confirmed 2025–26 escalation update.
- **Suggested fix:** Marked `[STALE but structural]`. Add "fresh check on YouTube enforcement 2025–26" to the Phase 8 validation/legal task (already in regulatory data gaps).

## Info
- All five deliverables carry the standard header (Phase/Project/Date/Confidence), a Data Gaps section, Red/Yellow Flags, and Sources. Structure-complete.
- Confidence ratings are internally consistent: usage-demand claims (multi-source T1/T2) rated High; WTP/market-size (indirect/T3) rated Low–Medium. Matches evidence.
- Cross-references between files are explicit and file-pathed per output guidelines.
- "Chronological is commoditizing → differentiate up-stack (completeness/organization/ownership)" is stated consistently across competitor-landscape, target-audience, and industry-trends — no contradiction.

## Verification Checklist
- [x] All quantitative claims labeled
- [x] No internal contradictions found
- [x] Confidence ratings consistent with evidence
- [x] Data gaps declared in all deliverables
- [x] Red/Yellow flags present in all deliverables
- [x] No stale data unmarked (Invidious 2023 + market base-years flagged)
- [x] No duplicate-source false corroboration (market-size reuse noted as Warning #1)
- [ ] Strategy reflects market data (cross-phase) — deferred, Phase 4 not yet done
- [ ] Product reflects customer pains (cross-phase) — deferred, Phase 6 not yet done
- [ ] Financial reflects business model (cross-phase) — deferred, Phase 7 not yet done
- [ ] Validation covers identified risks (cross-phase) — deferred, Phase 8 not yet done
